• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Perceived appropriateness of medication adherence incentives.对药物依从性激励措施的感知适宜性。
J Manag Care Spec Pharm. 2021 Jun;27(6):772-778. doi: 10.18553/jmcp.2021.27.6.772.
2
Individuals' preference for financial over social incentives for medication adherence.个体在药物依从性方面对经济激励而非社会激励的偏好。
J Am Pharm Assoc (2003). 2022 Jan-Feb;62(1):134-141.e1. doi: 10.1016/j.japh.2021.09.001. Epub 2021 Sep 8.
3
Patient preferences for medication adherence financial incentive structures: A discrete choice experiment.患者对药物依从性经济激励结构的偏好:一项离散选择实验。
Res Social Adm Pharm. 2021 Oct;17(10):1800-1809. doi: 10.1016/j.sapharm.2021.01.018. Epub 2021 Feb 5.
4
Financial incentives to improve adherence to antipsychotic maintenance medication in non-adherent patients: a cluster randomised controlled trial.针对未坚持服用抗精神病维持药物的患者,采用经济激励措施提高其依从性:一项整群随机对照试验。
Health Technol Assess. 2016 Sep;20(70):1-122. doi: 10.3310/hta20700.
5
Evaluating the relationship between quality measure adherence definitions and economic outcomes in commercial health plans: a retrospective diabetes cohort study.评估商业健康计划中质量衡量标准遵守情况的定义与经济结果之间的关系:一项回顾性糖尿病队列研究。
J Manag Care Spec Pharm. 2021 Jan;27(1):64-72. doi: 10.18553/jmcp.2021.27.1.064.
6
Assessing the association between medication adherence, as defined in quality measures, and disease-state control, health care utilization, and costs in a retrospective database analysis of Medicare supplemental beneficiaries using statin medications.在使用他汀类药物的 Medicare 补充受益人的回顾性数据库分析中,评估质量措施中定义的药物依从性与疾病控制、医疗保健利用和成本之间的关联。
J Manag Care Spec Pharm. 2020 Dec;26(12):1529-1537. doi: 10.18553/jmcp.2020.26.12.1529.
7
The association between health beliefs and medication adherence among patients with type 2 diabetes.2型糖尿病患者的健康信念与药物治疗依从性之间的关联。
Res Social Adm Pharm. 2016 Nov-Dec;12(6):914-925. doi: 10.1016/j.sapharm.2015.11.006. Epub 2015 Nov 22.
8
Unintentional non-adherence to chronic prescription medications: how unintentional is it really?慢性处方药非依从性:它真的有多不依从?
BMC Health Serv Res. 2012 Jun 14;12:98. doi: 10.1186/1472-6963-12-98.
9
Incentives and enablers to improve adherence in tuberculosis.提高结核病治疗依从性的激励因素和促进因素。
Cochrane Database Syst Rev. 2015 Sep 3;2015(9):CD007952. doi: 10.1002/14651858.CD007952.pub3.
10
Effect of Patient Financial Incentives on Statin Adherence and Lipid Control: A Randomized Clinical Trial.患者经济激励对他汀类药物依从性和血脂控制的影响:一项随机临床试验。
JAMA Netw Open. 2020 Oct 1;3(10):e2019429. doi: 10.1001/jamanetworkopen.2020.19429.

引用本文的文献

1
Effectiveness of eHealth for Medication Adherence in Renal Transplant Recipients: Systematic Review and Meta-Analysis.电子健康对肾移植受者药物依从性的有效性:系统评价与荟萃分析
J Med Internet Res. 2025 May 13;27:e73520. doi: 10.2196/73520.
2
Disease-Agnostic Electronic Adherence Aid for Subcutaneous at-Home and Self-Administration Devices-The Lowest Common Denominator Based on a Cross-Indication Survey.用于皮下家用和自我给药设备的疾病无关型电子依从性辅助工具——基于交叉适应症调查的最低标准
ACS Pharmacol Transl Sci. 2024 Apr 26;7(5):1310-1319. doi: 10.1021/acsptsci.3c00377. eCollection 2024 May 10.
3
The Impact of Non-Adherence to Antihypertensive Drug Therapy.不坚持抗高血压药物治疗的影响。
Healthcare (Basel). 2023 Nov 18;11(22):2979. doi: 10.3390/healthcare11222979.
4
Patient preferences for medication adherence financial incentive structures: A discrete choice experiment.患者对药物依从性经济激励结构的偏好:一项离散选择实验。
Res Social Adm Pharm. 2021 Oct;17(10):1800-1809. doi: 10.1016/j.sapharm.2021.01.018. Epub 2021 Feb 5.

本文引用的文献

1
Telepharmacy and medication adherence in urban areas.远程药学服务与城市地区的用药依从性。
J Am Pharm Assoc (2003). 2021 Mar-Apr;61(2):e100-e113. doi: 10.1016/j.japh.2020.10.017. Epub 2020 Nov 25.
2
Engaging Beneficiaries In Medicaid Programs That Incentivize Health-Promoting Behaviors.让参保人参与鼓励促进健康行为的医疗补助计划。
Health Aff (Millwood). 2019 Mar;38(3):431-439. doi: 10.1377/hlthaff.2018.05427.
3
The Effect of an Educational Intervention on Adherence to Intraocular Pressure-Lowering Medications in a Large Cohort of Older Adults with Glaucoma.一项教育干预对大量老年青光眼患者眼压降低药物治疗依从性的影响。
J Manag Care Spec Pharm. 2018 Dec;24(12):1284-1294. doi: 10.18553/jmcp.2018.17465. Epub 2018 May 31.
4
Hispanic health in the USA: a scoping review of the literature.美国西班牙裔健康状况:文献综述
Public Health Rev. 2016 Dec 7;37:31. doi: 10.1186/s40985-016-0043-2. eCollection 2016.
5
Nonadherence to Antihypertensive Medication Among Hypertensive Adults in the United States─HealthStyles, 2010.美国高血压成年人中抗高血压药物治疗的不依从性——健康风格,2010年
J Clin Hypertens (Greenwich). 2016 Sep;18(9):892-900. doi: 10.1111/jch.12786. Epub 2016 Feb 3.
6
The Ethics of Incentivizing Mammography Screening.激励乳腺钼靶筛查的伦理学问题
JAMA. 2015 Sep 8;314(10):995-6. doi: 10.1001/jama.2015.8852.
7
Patient-reported medication adherence barriers among patients with cardiovascular risk factors.心血管危险因素患者报告的药物依从性障碍。
J Manag Care Spec Pharm. 2015 Jun;21(6):479-85. doi: 10.18553/jmcp.2015.21.6.479.
8
Incentives for smoking cessation.戒烟的激励措施。
Cochrane Database Syst Rev. 2015 May 18(5):CD004307. doi: 10.1002/14651858.CD004307.pub5.
9
Pharmaceutical policies: effects of cap and co-payment on rational use of medicines.药品政策:封顶价和共付额对合理用药的影响。
Cochrane Database Syst Rev. 2015 May 8;2015(5):CD007017. doi: 10.1002/14651858.CD007017.pub2.
10
The role of behavioral economic incentive design and demographic characteristics in financial incentive-based approaches to changing health behaviors: a meta-analysis.行为经济激励设计和人口统计学特征在基于经济激励改变健康行为方法中的作用:一项荟萃分析。
Am J Health Promot. 2015 May-Jun;29(5):314-23. doi: 10.4278/ajhp.140714-LIT-333.

对药物依从性激励措施的感知适宜性。

Perceived appropriateness of medication adherence incentives.

机构信息

Department of Clinical Pharmacy and Outcomes Sciences, University of South Carolina College of Pharmacy, Columbia.

Department of Pharmacy Practice, Harrison School of Pharmacy, Auburn University, Auburn, AL.

出版信息

J Manag Care Spec Pharm. 2021 Jun;27(6):772-778. doi: 10.18553/jmcp.2021.27.6.772.

DOI:10.18553/jmcp.2021.27.6.772
PMID:34057397
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10391207/
Abstract

50% of prescriptions dispensed in the United States are not taken as prescribed, leading to approximately 125,000 deaths and 10% of hospitalizations per year. Incentives are effective in improving medication adherence; however, information about patient perceptions regarding incentives is lacking. To (1) explore perceived appropriateness of incentives among patients prescribed at least 1 medication for chronic hypertension, hyperlipidemia, heart disease, diabetes, and/or asthma/chronic obstructive pulmonary disease and (2) examine associations between perceived appropriateness and patient characteristics. A cross-sectional online survey was administered via Qualtrics Panels to US adults taking at least 1 prescription medication for a chronic condition. The results describe patient preference for financial or social recognition-based incentive, perceived appropriateness of adherence incentives (5-point Likert scale), self-reported adherence (Medometer), and demographics. Analyses included descriptive statistics with chi-square and independent t-tests comparing characteristics between participants who perceived incentives as being appropriate or inappropriate and logistic regression to determine predictors of perceived appropriateness. 1,009 individuals completed the survey. Of the 1,009 total survey participants, 933 (92.5%) preferred to receive a financial (eg, cash, gift card, or voucher) rather than a social recognition-based incentive (eg, encouraging messages, feedback, individual recognition, or team competition) for medication adherence. 740 participants (73%) perceived medication adherence incentives as being appropriate or acceptable as a reward given for taking medications at the right time each day, whereas 95 (9%) perceived incentives as being inappropriate. Remaining participants were neutral. Hispanic ethnicity (OR = 0.57; 95% CI = 0.37-0.89); income under $75,000 (OR = 0.48; 95% CI = 0.28-0.84); no college degree (OR = 0.60; 95% CI = 0.37-0.96); and adherence (OR = 0.99; 95% CI = 0.98-0.99) were significant predictors. The majority of patients perceived incentives as appropriate and preferred financial incentives over social recognition-based incentives. Perceived appropriateness for medication adherence incentives was less likely among certain groups of patients, such as those with Hispanic ethnicity, lower annual income, no college degree, and higher levels of adherence. These characteristics should be taken into account when structuring incentives. : This study was funded by the Auburn University's Intramural Grants Program. Hansen, Qian, and Garza are affiliated with Auburn University. Hansen has provided expert testimony for Daiichi Sankyo and Takeda on unrelated matters. The other authors have no potential conflicts of interest to declare. This study was presented as a poster presentation at the American Association of Colleges of Pharmacy Annual Meeting held July 2018 in Boston, MA.

摘要

50%的处方在美国没有按照规定服用,导致每年约有 12.5 万人死亡和 10%的住院治疗。激励措施在提高药物依从性方面是有效的;然而,关于患者对激励措施的看法的信息是缺乏的。(1)探讨至少有 1 种药物治疗慢性高血压、高血脂、心脏病、糖尿病和/或哮喘/慢性阻塞性肺疾病的患者对激励措施的感知适宜性;(2)检查感知适宜性与患者特征之间的关系。通过 Qualtrics Panels 对美国服用至少 1 种处方药治疗慢性疾病的成年人进行了横断面在线调查。结果描述了患者对基于财务或社会认可的激励措施的偏好、对药物依从性激励措施的感知适宜性(5 分李克特量表)、自我报告的依从性(Medometer)和人口统计学特征。分析包括描述性统计,采用卡方检验和独立 t 检验比较参与者中认为激励措施合适或不合适的特征,并进行逻辑回归以确定感知适宜性的预测因素。共有 1009 人完成了调查。在 1009 名总调查参与者中,933 名(92.5%)更愿意接受基于财务的激励措施(例如现金、礼品卡或代金券),而不是基于社会认可的激励措施(例如鼓励信息、反馈、个人认可或团队竞争),以提高药物依从性。740 名参与者(73%)认为药物依从性激励措施作为每天按时服药的奖励是合适或可以接受的,而 95 名参与者(9%)认为激励措施不合适。其余参与者持中立态度。西班牙裔(OR = 0.57;95% CI = 0.37-0.89);收入低于 75,000 美元(OR = 0.48;95% CI = 0.28-0.84);没有大学学位(OR = 0.60;95% CI = 0.37-0.96);和依从性(OR = 0.99;95% CI = 0.98-0.99)是显著的预测因素。大多数患者认为激励措施是合适的,并且更喜欢基于财务的激励措施而不是基于社会认可的激励措施。在某些患者群体中,如西班牙裔、年收入较低、没有大学学位和较高的依从性,药物依从性激励措施的感知适宜性较低。在制定激励措施时,应考虑到这些特征。本研究由奥本大学内部拨款计划资助。Hansen、Qian 和 Garza 隶属于奥本大学。Hansen 曾就与 Daiichi Sankyo 和 Takeda 无关的事项为其提供专家证言。其他作者没有潜在的利益冲突需要声明。本研究在美国药学院协会年度会议上以海报形式展示,该会议于 2018 年 7 月在马萨诸塞州波士顿举行。